Find clinical trials for Ophthalmology. Search for Ophthalmology clinical trials in different cities and states across the United States.
Sponsor:
University of Washington
Location:
Code:
NCT05277870
Conditions
Glaucoma, Open-Angle
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nanodropper adaptor
control
Sponsor:
UCLA
Location:
Code:
NCT05296837
Conditions
Ocular Rosacea
Antimicrobial Resistance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Doxycycline 40 MG ( 20mg twice daily)
Doxycycline 200 MG ( 100 mg twice daily)
Placebo
Sponsor:
Massachusetts Eye and Ear Infirmary
Location:
Code:
NCT05145959
Conditions
Stevens-Johnson Syndrome
Toxic Epidermal Necrolyses
Ocular Surface Disease
Meibomitis
Meibomian Gland Dysfunction
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Maskin Probe
Sponsor:
Evolutec Group
Location:
Code:
NCT00353964
Conditions
Ocular Inflammation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
rEV131
Prenisolone sodium phosphate 1.0%
rEV131 vehicle
Sponsor:
59th Medical Wing
Location:
Code:
NCT05844384
Conditions
Ocular Hypertension
Primary Open Angle Glaucoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nanodropper
Regular dropper
Sponsor:
Dr. David Yan
Location:
Code:
NCT02792803
Conditions
POAG
Primary Open Angle Glaucoma
Ocular Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Xalatan
Apo-Latanoprost
Co-Latanoprost
Sponsor:
UCLA
Location:
Code:
NCT06859216
Conditions
Ophthalmic Disease
Artifical Intelligence
Large Language Model
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
AI-Generated Plain Language Summaries
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Location:
Code:
NCT05524935
Conditions
Uveal Melanoma
Ocular Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Olaparib
Sponsor:
MD Stem Cells
Location:
Code:
NCT03011541
Conditions
Retinal Disease
Age-Related Macular Degeneration
Retinitis Pigmentosa
Stargardt Disease
Optic Neuropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Arm 1
Ophthalmology clinical trials are research studies designed to evaluate new treatments, therapies, or diagnostic methods for eye diseases and conditions. These trials focus on a wide range of ophthalmic issues, including but not limited to glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, cataracts, and retinal diseases. Clinical trials in ophthalmology may test new medications, surgical techniques, laser treatments, or medical devices to improve vision, prevent blindness, or manage symptoms of eye diseases.
The data collected from these trials helps advance understanding and development of better treatment options, ultimately aiming to enhance eye health and visual outcomes for patients.
With a vast range of eye conditions and diseases falling under the ophthalmology umbrella, clinical research in this area is highly important. Ophthalmology clinical trials are crucial for driving the development of new and more effective treatments for eye diseases and conditions, which can significantly impact vision and quality of life.
Clinical trials for ophthalmology help researchers to evaluate novel medications, surgical techniques, and diagnostic tools, potentially leading to breakthroughs in managing or curing a range of conditions. Ophthalmology clinical trials play a key role in reducing the burden of visual impairment and blindness, enhancing eye health, and promoting better visual outcomes for future patients.
Clinical trials in ophthalmology employ various types and methodologies to evaluate new treatments, technologies, and diagnostic approaches for eye diseases. Researchers will determine the design and type of clinical trial they use depending on the study objectives.
Prevention trials in ophthalmology are used to explore and evaluate strategies designed to prevent the onset or progression of eye diseases. These trials test various approaches, such as lifestyle changes, nutritional interventions, or early treatments, to reduce the risk of developing conditions like age-related macular degeneration, diabetic retinopathy, or glaucoma.
By identifying effective preventive measures and interventions, these trials aim to improve long-term eye health, delay disease onset, and reduce the burden of visual impairment. Participants in prevention trials contribute to understanding how to better safeguard eye health and develop strategies to maintain or enhance vision throughout life.
Researchers use ophthalmology observational trials to gather data on the natural progression of eye diseases, treatment responses, and the impact of various factors without administering experimental interventions. Patients are monitored over time to understand how conditions like glaucoma, age-related macular degeneration, or diabetic retinopathy develop and respond to standard care.
These trials help identify patterns, risk factors, and outcomes, providing insights into disease mechanisms and the effectiveness of existing treatments. The findings from observational trials contribute to improving diagnostic criteria, refining treatment strategies, and enhancing patient management in ophthalmology.
Ophthalmology researchers can use treatment trials when testing the safety and effectiveness of new treatments, procedures, or devices for managing eye diseases and conditions. Participants in these trials receive experimental interventions, such as novel medications, advanced surgical techniques, or innovative laser therapies, and are closely monitored for their effects on vision and eye health.
Treatment trials for ophthalmology assess how the given interventions impact disease progression, symptom relief, and overall visual outcomes. By evaluating these new approaches, researchers using this trial type can support the identification of more effective treatments, improve patient care, and advance the field of ophthalmology.
Taking part in a clinical trial for ophthalmology offers many different benefits for participants, especially those already diagnosed with various eye conditions. It’s important to remember that participation in an ophthalmology clinical trial can also come with risks and considerations too.
Access to cutting-edge treatments and technologies is one of the main benefits of participating in a clinical trial for ophthalmology. These treatments may not be available through standard care so participants will have first access to them. Participants usually receive close monitoring and specialized care from experts, which can lead to early detection of issues and personalized management of their eye condition. This high level of care can be an improvement to the treatment or care they receive outside the trial.
Additionally, involvement in a trial contributes to advancing medical research, helping to develop new therapies and improve treatment options for future patients. For some, participating may also provide an opportunity to experience potential improvements in vision and overall eye health.
Like any research study, participating in a clinical trial for ophthalmology involves risks and considerations. One such risk is the potential for exposure to unknown side effects from experimental treatments or procedures, which may be different from standard care or currently available treatments. There is also no guarantee that the new intervention will be effective or improve your condition.
In terms of considerations before signing up, participants might also face frequent medical visits, tests, and additional procedures, which can become burdensome and require a change in their daily routine.
Eligibility for participating in a clinical trial for ophthalmology typically includes individuals diagnosed with specific eye conditions or diseases under investigation, such as glaucoma, age-related macular degeneration, or diabetic retinopathy. When establishing criteria, researchers will often consider factors like the severity of the condition, overall health, age, and previous treatments.
Some clinical trials for ophthalmology will focus on particular subgroups, such as those with early-stage disease or those who have not responded to standard treatments. Healthy volunteers may also be included in some trials for comparison purposes.
Unsure about participating in clinical trials? Read through our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
Participants in a clinical trial for ophthalmology can first expect to undergo a detailed screening process to determine eligibility. This often includes medical evaluations and informed consent discussions. If enrolled, the clinical trial can begin as per the trial design. This could be in the form of receiving the assigned intervention, which could be a new treatment, procedure, or medical device. Participants are closely monitored through regular visits, tests, and assessments to evaluate the safety and effectiveness of the treatment.
Throughout the course of the trial, participants might need to follow specific protocols or lifestyle adjustments related to the trial. Throughout the process, the research team will regularly interact, providing support and ensuring participant safety while collecting valuable data to advance eye care and treatment.
Enrolling in a clinical trial studying ophthalmology through our platform is a straightforward and user-friendly process. Here's how to get started: